Date post: | 27-Feb-2018 |
Category: |
Documents |
Upload: | nirmalkumaar88 |
View: | 217 times |
Download: | 0 times |
of 23
7/25/2019 07 Insulin Therapy
1/23
Clinical Practice Guidelines:Management of
Type 2 Diabetes Mellitus
(4thEdition 2!!"
Topic 7:
#nsulin Therapy
7/25/2019 07 Insulin Therapy
2/23
2
Targets for Control
LevelsGlycaemic Control $
%asting 4&4 ' &) mmol*l
+on,fasting 4&4 ' -&! mmol*l
.b/)c
7/25/2019 07 Insulin Therapy
3/23
Diagnosis of Type 2 DiabetesAll patients advised LIFESTLE !odification
F"$ %bA&cat Diagnosis and Follo' (p
%bA&c
)+,- ./
F" ) 00ol1L
LIFESTYLE
APPROACH*
Follow-up with HbA1c
after
3 months.
If HbA1c6.5%,continuewith ifest!le Approach.
If HbA1c
"6.5% on follow-
up, consi#er OAD
MONOTHERAPY.
%bA&c
+, )3+4-
./
F" )&4 00ol1LOAD MONOTHERAPY
$etformin
&'
A(I ) *++- Inhibitor )
(lini#es ) ) /0*s.
&ptimise #ose of &A* aent
in the subse2uent 3-6
months.
Follow-up with HbA1c
after 3-6
months.
If HbA1c
6.5%, continue
therap!.
If HbA1c"6.5%, consi#erCOMBINATION OAD
THERAPY.
%bA&c
5&4+4- ./
F" 5&6 00ol1LCOMBINATION
THERAPY + BASAL /
PREMIXED INSULIN
THERAPY.
&'
INTENSIVE INSULINTHERAPY, contin!
M!t"o#$in.
%bA&c
3+4&4+4- ./
F" &4&6 00ol1L
COMBINATION THERAPY***
$etformin with other &A*
aents A(I ) *++-
Inhibitor ) (lini#es ) Incretin
$imetic ) ) /0*s4 or withinsulin.
&ptimise #ose of &A* aents
in the subse2uent 3-6
months.
Follow-up with HbA1c
after 3-6
months.
If HbA1c
6.5%, continue
therap!.If HbA
1c"6.5%, consi#er
a##ition of INSULIN
THERAPY.
Teat0ent Algoit80 fo t8e !anage0ent of T2D!
Footnote:
If symptomatic (weight loss, polyuria, etc) at any HbA1cand FPG level, consider insulin therapy
! "onsider metformin#AGI#other insulin sensitiser in appropriate patients!! $etformin is preferred %st line agent, and &' should preferably not be used as %stline
!!! Although oral agents can be used, initiation and intensification of insulin therapy is preferred based oneffectiveness and epense
7/25/2019 07 Insulin Therapy
4/23
4
Combination of @ral /gents A
#nsulin Therapy
B Combining insulin and the follo6ing @/Dagents has been sho6n to be effecti
7/25/2019 07 Insulin Therapy
5/23
0
hort Term se of #nsulin
S8otte0 ins(lin t8eapy s8o(ld be
consideed in t8e follo'ing conditions:
B /cute illness> surgery> stress and emergencies
B Pregnancy
B 8reast,feeding
B #nsulin may be used as initial therapy in T2DM
particularly in mar7ed hyperglycaemiaB e
.@+
7/25/2019 07 Insulin Therapy
6/23
ong Term se of #nsulin
B Persistent hyperglycaemia in spite of optimal@/D agents 6ith stable or loss of 6eightsuggests beta cell failure& .o6e it isimportant to e5clude chronic infections>
malignancies or medications as cause of 6eightloss&
B The basal intermediate acting insulin should beadministered pre,bed because of the ris7 of
hypoglycaemia in the early hours of the morningif gi
7/25/2019 07 Insulin Therapy
7/23
3
ong Term se of #nsulin(cont&
B 9eFuirements of high dose of insulin ()&0 unit*7g perday should prompt a search for an underlyingcause*secondary problems such as non,compliance>incorrect dosing and administration timing> hypertrophy
of inHection area> inter meal hypoglycaemia 6ith reboundhyperglycaemia pre,meal> e5pired insulin or e5piredstrips and occult infections&
B There is no limitation of insulin dose&
B The rate of absorption from the inHections depend on thesite and Ie5ercise acti
7/25/2019 07 Insulin Therapy
8/23
-
#nsulin #nitiation
B #f targets ha consider adding:
' Pre,bed intermediate,acting> or
' Pre,bed long,acting insulin> or' Pre,dinner premi5ed insulin
7/25/2019 07 Insulin Therapy
9/23
"
#nsulin @ptimisation
B Dose of insulin can be increased e
7/25/2019 07 Insulin Therapy
10/23
)!
#nsulin #ntensification
B 8edtime basal insulin premi5ed insulin daily *
t6ice daily
B 8edtime basal insulin seFuential addition of
bolus insulin premeals (8// PB 8edtime basal insulin addition of three bolus
insulin (8// 8@
B ingle premi5ed dose T6ice then maybethrice daily )2 (premi5ed analogue
7/25/2019 07 Insulin Therapy
11/23
))
Types of #nsulin 9egimes
B @/D agents K basal insulin or premi5ed insulin
once a day
B Metformin K premi5ed insulin more than once a
dayB Metformin K basal insulin K prandial insulin
7/25/2019 07 Insulin Therapy
12/23
)2
elf 8lood Glucose Monitoring
B Method of choice in monitoring glycaemic control& 8GMshould be carried out for patients on insulin and isdesirable for those on @/D agents&
B %reFuency of blood glucose testing depends on the
glucose status> glucose goals and mode of treatment&B /lthough 8GM has not been sho6n to ha it is recommended as part of a 6idereducational strategy to promote self,care&
B 8GM should be carried out or 4 times daily forpatients using multiple insulin inHections or insulin pumptherapy
7/25/2019 07 Insulin Therapy
13/23
)
Monitoring , 8GM
!ode ofTeat0ent
9eafast L(nc8 Dinne
"e "ost "e "ost "e"ost 1
"ebed
Diet @nly
@ral anti,diabeticagent
#nsulin
9ecommended timing of 8GM
@ptional timing of 8GM
7/25/2019 07 Insulin Therapy
14/23
)4
9eaching Glycaemic Targets
To contol Ad;(st
"ebeafastgl(cose
Pre bed intermediate acting insulin or long acting analogueor pre,dinner premi5ed
28o( post
beafast
8rea7fast inta7e or pre brea7fast rapid acting or morning
premi5ed insulin analogue
"el(nc8gl(cose
Morning tea or pre brea7fast short acting insulin or morningpremi5ed insulin
28o( postl(nc8
unch inta7e or pre lunch rapid acting or morning premi5edinsulin
"edinne /fternoon tea inta7e or pre lunch short acting insulin ormorning premi5ed insulin
"ostdinne 1pebed
Dinner inta7e or pre dinner rapid acting or pre dinnerpremi5ed analogue or pre dinner premi5ed insulin
7/25/2019 07 Insulin Therapy
15/23
)0
Glucose Monitoring in 9elation to
#nsulin Therapy
B Those on replacement insulin therapy need tochec7 glucose le
7/25/2019 07 Insulin Therapy
16/23
)
@ral /gents K 8edtime #nsulin
%igure )a: @ral /gent(s K 8edtime #nsulin ' #ntermediate /cting #nsulin
9ecommended timing of 8GM
7/25/2019 07 Insulin Therapy
17/23
)3
@ral /gents K 8edtime #nsulin (cont&
9ecommended timing of 8GM
%igure )b: @ral /gent(s K @nce Daily 8asal ong /cting #nsulin
B=alues before brea7fast gi
7/25/2019 07 Insulin Therapy
18/23
)-
8asal 8olus #nsulin 9egimen
%igure 2: 8asal 8olus #nsulin 9egimen
7/25/2019 07 Insulin Therapy
19/23
)"
8asal 8olus #nsulin 9egimen (cont&
B =alues before brea7fast gi
7/25/2019 07 Insulin Therapy
20/23
2!
T6ice Daily Premi5ed or
Combination #ntermediate /cting
6ith hort /cting #nsulin
%igure : #ntermediate /cting 6ith hort /cting #nsulin
7/25/2019 07 Insulin Therapy
21/23
2)
T6ice Daily Premi5ed or
Combination #ntermediate /cting
6ith hort /cting #nsulin (cont&B =alues before brea7fast gi
7/25/2019 07 Insulin Therapy
22/23
22
eys to success 6ith insulin
B tart early
B tart simply ' easy regimen
B 8GM ' monitor regularly
B /
7/25/2019 07 Insulin Therapy
23/23
2
Thank you